title: Can involving diabetes specialists in developing a new insulin pen result in patient benefits?
authors.affiliation: Department of Medicine, Helsinki University Hospital, Finland.
authors.forename: V
authors.initials: V
authors.lastname: Koivisto
authors.forename: N
authors.initials: N
authors.lastname: Chatterton
authors.forename: D
authors.initials: D
authors.lastname: Hicks
authors.forename: P C
authors.initials: PC
authors.lastname: Bates
authors.forename: J A
authors.initials: JA
authors.lastname: Llewelyn
mesh_terms: D003253:Consultants; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004867:Equipment Design; D006801:Humans; D007267:Injections / Q000295:instrumentation*; D007328:Insulin / Q000008:administration & dosage*; D010353:Patient Education as Topic; D012646:Self Administration
chemical_list: D007328:Insulin